Literature DB >> 3416069

The putative factor IX gene promoter in hemophilia B Leyden.

P H Reitsma1, R M Bertina, J K Ploos van Amstel, A Riemens, E Briët.   

Abstract

Hemophilia B Leyden is characterized by low levels of factor IX antigen and activity before the age of 15, whereas after puberty factor IX levels rise at a rate of about 5% per year. A single base substitution (-A----T) at position -20 was identified in the putative promoter of the gene cloned from a patient with hemophilia B Leyden. This nucleotide change was confirmed in a second patient from the same pedigree and was also found in a patient from a second Dutch pedigree with the same hemophilic phenotype. The results indicate that the two Dutch kindreds are related and point to the functional significance of the -20 position for the expression of the human factor IX gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3416069

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  A new strategy for the genetic counselling of diseases of marked mutational heterogeneity: haemophilia B as a model.

Authors:  F Giannelli; S Saad; A J Montandon; D R Bentley; P M Green
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Clinical utility gene card for: haemophilia B.

Authors:  Peter Vincent Jenkins; Catriona Keenan; Steve Keeney; Tony Cumming; James S O'Donnell
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

3.  A rapid test for V(D)J recombinase activity.

Authors:  S Kallenbach; M Goodhardt; F Rougeon
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

4.  Comparative sequence analysis of mammalian factor IX promoters.

Authors:  C P Pang; M Crossley; G Kent; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

5.  Haemophilia B: database of point mutations and short additions and deletions--second edition.

Authors:  F Giannelli; P M Green; K A High; S Sommer; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

6.  Haemophilia B: database of point mutations and short additions and deletions--third edition, 1992.

Authors:  F Giannelli; P M Green; K A High; S Sommer; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

7.  An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B Leyden.

Authors:  Sumiko Kurachi; Jeffrey S Huo; Afshin Ameri; Kezhong Zhang; Akiyasu C Yoshizawa; Kotoku Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

8.  A less severe form of Haemophilia B Leyden.

Authors:  M Crossley; P R Winship; D E Austen; C R Rizza; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

9.  Haemophilia B: database of point mutations and short additions and deletions.

Authors:  F Giannelli; P M Green; K A High; J N Lozier; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

10.  Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins.

Authors:  S G Spitzer; B J Warn-Cramer; C K Kasper; S P Bajaj
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.